THE ROLE OF RADIOTHERAPY IN THE TREATMENT STRATEGY OF TESTICLE TUMOURS

Česká verzia

Authors: doc. MUDr. Pavel Šlampa, CSc.; MUDr. Blažena Syptáková
Authors place of work: oddělení radiační onkologieMasarykův onkologický ústav, Brno
Published in the journal: Urol List 2006; 4(3): 33-38

Summary

Radiotherapy is indispensable in the treatment of seminomas. It has produced excellent results in the treatment of this disease, especially in its use, thus far, as a standard adjuvant treatment of stage I and curative treatment of stages IIA and IIB. The role of radiation of residual mass after chemotherapy in advanced or metastatic cases is debatable. In cases following surgery (orchiopexis, groin hernia surgery), apart from same-side radiation of the ilical area, double-sided inguinopelvic area radiation is done using the technique of two oppositely laid poles in the shape of an inverted ”Y“. Radiation of the hemiscrotum is not necessary if it was not preceded by adequate steps like orchiectomy or diagnostic abjection through puncture or excision, all of which could result in the contamination of the scrotum and a real danger of local deterioration. Radiotherapy in non-seminomas is generally indicated as a palliative treatment, or in individual cases as adjuvant - radiation of residual infiltrates after chemotherapy (when they are inoperable)

KEY WORDS:
radiotherapy, seminoma, non-seminoma

Zdroje

1. Abrahámová J. Nádory varla. Praha: Triton 2001: 100.

2. Abrahámová J, Povýšil C, Novák J et al. Nádory varlat a penisu. Praha: Triton 2005: 30

3. Adam Z, Vorlíček J et al. Speciální onkologie. Brno: MÚ 2002: 166-176.

4. Adam Z, Vorlíček J, Vaníček J et al. Diagnostické a léčebné postupy u maligních chorob. 1. vyd. Praha: Grada 2002: 185-196.

5. Šlampa P, Petera J et al. Radiační onkologie. 1. vyd. Praha: Galén 2006, v tisku.

6. Dieckmann KP, Besserer A, Loy V. Low-dose radiation therapy for testicular intraepithelial neoplasia. J Cancer Res Clin Oncol 1993; 119(6): 355-359.

7. Šlampa P et al. Radiační onkologie v praxi. Brno: MOÚ 2004: 128-134.

8. Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 1999; 17: 1146-1153.

9. Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma. J Clin Oncol 1999; 17(4): 1146.

10. Perez CA, Brady LW (ed.). Principles & Practice of Radiation Oncology. 4rd ed. Philadelphia: Lippincott& Wilkins 2004: 1763-1799.

11. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. International Commission for Radiation Units and Measurements, Bethesda, MD 1993: 71.

12. Heindereich A. Therapeutical option for seminomas at clinical stage I-II A. Urologe 2005; 43(8): 1435-1444.

13. UICC. TNM klasifikace zhoubných novotvarů. 6. vyd. Praha: ÚZIS 2004: 156-160.

14. Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 21: 4448-4452.

15. Classen J, Schmidberger H, Meisner C et al. Radiotherapy for stages IIA/B testicular seminoma. J Clin Oncol 2003; 21(6): 1101-1106.

16. Milosevic MF, Gospodarowicz M, Warde P. Management of testicular seminoma. Semin Surg Oncol 1999; 17: 240-249.